Joseph Wedekind
Concepts (249)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of publications
|
Most recent publication
|
Publications by all authors
|
Why?
|
|---|
RNA, Catalytic | 17 | 1998 | 13 |
Why?
| Crystallography, X-Ray | 23 | 1994 | 41 |
Why?
| Models, Molecular | 29 | 1995 | 102 |
Why?
| Cytidine Deaminase | 9 | 2003 | 15 |
Why?
| Nucleic Acid Conformation | 16 | 1998 | 56 |
Why?
| Catalytic Domain | 6 | 1999 | 27 |
Why?
| Crystallization | 11 | 1994 | 34 |
Why?
| Metals | 5 | 1995 | 35 |
Why?
| Imines | 2 | 2009 | 3 |
Why?
| Binding Sites | 17 | 1994 | 213 |
Why?
| Hepatitis Delta Virus | 2 | 2005 | 1 |
Why?
| RNA, Viral | 3 | 2005 | 91 |
Why?
| Water | 2 | 2006 | 85 |
Why?
| MNSs Blood-Group System | 2 | 2004 | 3 |
Why?
| Ammonia-Lyases | 3 | 1996 | 2 |
Why?
| Immunoglobulin Fab Fragments | 2 | 2004 | 23 |
Why?
| Protein Conformation | 12 | 1994 | 123 |
Why?
| Pseudomonas putida | 2 | 2004 | 4 |
Why?
| Magnesium | 4 | 1994 | 69 |
Why?
| RNA | 4 | 2000 | 126 |
Why?
| X-Ray Diffraction | 6 | 2000 | 14 |
Why?
| Riboswitch | 1 | 2011 | 1 |
Why?
| Ions | 1 | 2011 | 29 |
Why?
| Phosphopyruvate Hydratase | 5 | 1994 | 24 |
Why?
| Biopolymers | 1 | 2009 | 12 |
Why?
| Nepovirus | 1 | 2009 | 1 |
Why?
| Spectrum Analysis, Raman | 1 | 2009 | 7 |
Why?
| Aptamers, Nucleotide | 1 | 2009 | 1 |
Why?
| Pyrroles | 1 | 2009 | 13 |
Why?
| Lead | 2 | 1999 | 55 |
Why?
| Protein Structure, Tertiary | 8 | 2001 | 163 |
Why?
| Pyrimidinones | 1 | 2009 | 14 |
Why?
| RNA Editing | 3 | 2003 | 10 |
Why?
| Ribonucleases | 1 | 2008 | 42 |
Why?
| Magnetic Resonance Spectroscopy | 1 | 2009 | 74 |
Why?
| UTP-Hexose-1-Phosphate Uridylyltransferase | 3 | 1995 | 3 |
Why?
| Inosine | 1 | 2007 | 5 |
Why?
| Molecular Sequence Data | 12 | 1995 | 404 |
Why?
| Phosphorus | 2 | 1996 | 29 |
Why?
| Phase Transition | 1 | 2007 | 3 |
Why?
| Anti-HIV Agents | 1 | 2009 | 44 |
Why?
| Guanosine | 1 | 2007 | 12 |
Why?
| Protein Folding | 2 | 2004 | 30 |
Why?
| Vanadates | 1 | 2007 | 13 |
Why?
| Catalysis | 7 | 1996 | 40 |
Why?
| Models, Chemical | 4 | 2005 | 57 |
Why?
| Nucleoside Deaminases | 1 | 2006 | 10 |
Why?
| Saccharomyces cerevisiae | 4 | 1994 | 67 |
Why?
| Protein Structure, Secondary | 8 | 1994 | 54 |
Why?
| Immunoglobulin Fragments | 1 | 2005 | 13 |
Why?
| Uracil | 1 | 2005 | 18 |
Why?
| Hydrogen Bonding | 4 | 1996 | 24 |
Why?
| Structure-Activity Relationship | 5 | 2001 | 124 |
Why?
| RNA Stability | 1 | 2007 | 38 |
Why?
| Amino Acid Sequence | 11 | 1994 | 319 |
Why?
| Blood Proteins | 1 | 2005 | 71 |
Why?
| DNA, Single-Stranded | 2 | 2004 | 32 |
Why?
| Crystallins | 1 | 2004 | 3 |
Why?
| Escherichia coli | 4 | 1995 | 143 |
Why?
| Repressor Proteins | 1 | 2006 | 96 |
Why?
| Electrons | 3 | 2005 | 10 |
Why?
| Ligands | 5 | 1996 | 116 |
Why?
| Base Sequence | 6 | 1998 | 371 |
Why?
| Kinetics | 8 | 1995 | 349 |
Why?
| Molecular Structure | 6 | 1995 | 67 |
Why?
| Hydrogen-Ion Concentration | 5 | 1995 | 176 |
Why?
| Apolipoproteins B | 2 | 2003 | 18 |
Why?
| Exotoxins | 1 | 2001 | 9 |
Why?
| ADP Ribose Transferases | 1 | 2001 | 9 |
Why?
| Bacterial Toxins | 1 | 2001 | 24 |
Why?
| Carrier Proteins | 1 | 2005 | 177 |
Why?
| Virulence Factors | 1 | 2001 | 24 |
Why?
| RNA, Messenger | 3 | 2003 | 394 |
Why?
| Pseudomonas aeruginosa | 1 | 2001 | 33 |
Why?
| Saccharomyces cerevisiae Proteins | 1 | 2004 | 58 |
Why?
| Substrate Specificity | 4 | 1996 | 90 |
Why?
| HIV-1 | 4 | 2006 | 93 |
Why?
| Molecular Weight | 2 | 2006 | 154 |
Why?
| Protein Binding | 5 | 1994 | 256 |
Why?
| Sequence Homology, Amino Acid | 5 | 1996 | 156 |
Why?
| Dimerization | 3 | 2004 | 92 |
Why?
| Drug Resistance, Viral | 2 | 2006 | 17 |
Why?
| Histidine | 1 | 1996 | 42 |
Why?
| Cytoplasm | 2 | 2006 | 108 |
Why?
| Sequence Alignment | 4 | 2001 | 114 |
Why?
| RNA Processing, Post-Transcriptional | 2 | 2004 | 33 |
Why?
| Phosphonoacetic Acid | 1 | 1994 | 1 |
Why?
| HIV Reverse Transcriptase | 2 | 2005 | 16 |
Why?
| Hydroxamic Acids | 1 | 1994 | 18 |
Why?
| Mutation | 4 | 2001 | 340 |
Why?
| Cloning, Molecular | 3 | 2004 | 183 |
Why?
| Humans | 16 | 1995 | 1856 |
Why?
| Serine | 1 | 1994 | 62 |
Why?
| Cell Line | 6 | 2006 | 375 |
Why?
| Amino Acid Substitution | 3 | 2005 | 68 |
Why?
| Stereoisomerism | 3 | 1996 | 31 |
Why?
| vif Gene Products, Human Immunodeficiency Virus | 2 | 2007 | 2 |
Why?
| Second Messenger Systems | 1 | 2011 | 19 |
Why?
| Amino Acid Motifs | 3 | 2004 | 52 |
Why?
| Coenzymes | 1 | 2011 | 16 |
Why?
| Base Composition | 2 | 1998 | 20 |
Why?
| Recombinant Proteins | 2 | 2004 | 290 |
Why?
| Cyclic GMP | 1 | 2011 | 30 |
Why?
| Electrophoresis, Polyacrylamide Gel | 2 | 1994 | 167 |
Why?
| Fourier Analysis | 1 | 2009 | 23 |
Why?
| Thermoanaerobacter | 1 | 2009 | 1 |
Why?
| Bacillus subtilis | 1 | 2009 | 11 |
Why?
| RNA, Untranslated | 1 | 2009 | 15 |
Why?
| HIV Core Protein p24 | 1 | 2008 | 17 |
Why?
| Base Pairing | 1 | 2009 | 13 |
Why?
| Adenine | 1 | 2008 | 26 |
Why?
| Protein Sorting Signals | 1 | 2007 | 19 |
Why?
| Deoxyribonucleotides | 1 | 2008 | 8 |
Why?
| Uridine | 1 | 2007 | 23 |
Why?
| Recombinant Fusion Proteins | 2 | 2005 | 189 |
Why?
| Heterogeneous-Nuclear Ribonucleoproteins | 1 | 2006 | 8 |
Why?
| Mutation, Missense | 1 | 2008 | 59 |
Why?
| Nanostructures | 1 | 2006 | 8 |
Why?
| Bicyclo Compounds, Heterocyclic | 1 | 2006 | 14 |
Why?
| HIV Protease | 1 | 2006 | 7 |
Why?
| Scattering, Radiation | 1 | 2006 | 36 |
Why?
| Drug Design | 1 | 2006 | 33 |
Why?
| Cell Nucleus | 2 | 2006 | 169 |
Why?
| Hepatitis delta Antigens | 1 | 2005 | 1 |
Why?
| Macromolecular Substances | 3 | 1994 | 92 |
Why?
| Alkanesulfonic Acids | 1 | 2005 | 2 |
Why?
| Cryoprotective Agents | 1 | 2005 | 4 |
Why?
| Maltose-Binding Proteins | 1 | 2005 | 5 |
Why?
| Phylogeny | 1 | 2006 | 63 |
Why?
| Glycophorin | 1 | 2005 | 7 |
Why?
| Carbohydrates | 1 | 2005 | 14 |
Why?
| RNA-Binding Proteins | 1 | 2007 | 55 |
Why?
| Glycopeptides | 1 | 2005 | 9 |
Why?
| Galactose | 1 | 2005 | 14 |
Why?
| HIV Protease Inhibitors | 1 | 2006 | 25 |
Why?
| Biotechnology | 1 | 2005 | 16 |
Why?
| Molecular Conformation | 1 | 2005 | 31 |
Why?
| Thymine Nucleotides | 1 | 2005 | 8 |
Why?
| Glycerol | 1 | 2005 | 24 |
Why?
| Glycosylation | 1 | 2005 | 37 |
Why?
| Morpholines | 1 | 2005 | 28 |
Why?
| IMP Dehydrogenase | 1 | 2005 | 9 |
Why?
| Sulfonamides | 1 | 2006 | 74 |
Why?
| Binding, Competitive | 1 | 2006 | 109 |
Why?
| Solubility | 1 | 2005 | 75 |
Why?
| Hydroxyl Radical | 1 | 2005 | 15 |
Why?
| Codon | 1 | 2005 | 41 |
Why?
| Antigens | 1 | 2005 | 66 |
Why?
| Macrophages | 1 | 2008 | 148 |
Why?
| Zinc | 2 | 1995 | 37 |
Why?
| Ornithine | 1 | 2004 | 4 |
Why?
| Dinucleotide Repeats | 1 | 2004 | 3 |
Why?
| Gene Expression Regulation | 1 | 2011 | 277 |
Why?
| Transcription, Genetic | 1 | 2009 | 253 |
Why?
| Deamination | 1 | 2004 | 3 |
Why?
| Multigene Family | 1 | 2004 | 52 |
Why?
| Somatic Hypermutation, Immunoglobulin | 1 | 2004 | 8 |
Why?
| Software | 1 | 2005 | 92 |
Why?
| Histocompatibility Antigens Class II | 1 | 2006 | 50 |
Why?
| Antibodies | 1 | 2005 | 159 |
Why?
| NAD | 1 | 2004 | 41 |
Why?
| Automation | 1 | 2004 | 27 |
Why?
| Iron | 2 | 1995 | 75 |
Why?
| Peptides | 1 | 2006 | 154 |
Why?
| Antigen-Antibody Complex | 1 | 2004 | 34 |
Why?
| Immunoglobulin M | 1 | 2004 | 81 |
Why?
| Strontium | 1 | 2003 | 6 |
Why?
| Allosteric Site | 1 | 2003 | 6 |
Why?
| Syndrome | 1 | 2004 | 142 |
Why?
| CD4-Positive T-Lymphocytes | 1 | 2006 | 113 |
Why?
| Neurofibromin 1 | 1 | 2003 | 3 |
Why?
| Mammals | 1 | 2003 | 47 |
Why?
| Furin | 1 | 2001 | 4 |
Why?
| Pliability | 1 | 2001 | 9 |
Why?
| Static Electricity | 1 | 2001 | 17 |
Why?
| Subtilisins | 1 | 2001 | 10 |
Why?
| Animals | 5 | 2003 | 1031 |
Why?
| Point Mutation | 1 | 2002 | 122 |
Why?
| Models, Biological | 1 | 2007 | 410 |
Why?
| Rabbits | 1 | 2003 | 252 |
Why?
| HIV Infections | 1 | 2008 | 136 |
Why?
| Carboxylic Acids | 2 | 1996 | 9 |
Why?
| Computer Simulation | 1 | 2001 | 134 |
Why?
| Chromatography, High Pressure Liquid | 1 | 2000 | 121 |
Why?
| DNA-Binding Proteins | 1 | 2004 | 204 |
Why?
| Electrochemistry | 2 | 1995 | 32 |
Why?
| Protein Structure, Quaternary | 2 | 2008 | 18 |
Why?
| Cations, Divalent | 1 | 1998 | 20 |
Why?
| Nuclear Magnetic Resonance, Biomolecular | 1 | 1998 | 11 |
Why?
| Intramolecular Lyases | 1 | 1996 | 1 |
Why?
| Uridine Monophosphate | 1 | 1996 | 3 |
Why?
| Consensus Sequence | 1 | 1996 | 39 |
Why?
| DNA, Viral | 2 | 2008 | 98 |
Why?
| Protein Transport | 2 | 2006 | 101 |
Why?
| Hexoses | 1 | 1995 | 4 |
Why?
| Metalloproteins | 1 | 1995 | 8 |
Why?
| Mice | 2 | 2003 | 623 |
Why?
| Chelating Agents | 1 | 1994 | 45 |
Why?
| Thermodynamics | 1 | 1994 | 45 |
Why?
| Mutagenesis, Site-Directed | 2 | 1996 | 126 |
Why?
| gag Gene Products, Human Immunodeficiency Virus | 1 | 2007 | 5 |
Why?
| Lamivudine | 1 | 2008 | 18 |
Why?
| Retroelements | 1 | 2007 | 11 |
Why?
| Reverse Transcriptase Inhibitors | 1 | 2008 | 19 |
Why?
| Glyceric Acids | 2 | 1996 | 2 |
Why?
| Takifugu | 1 | 2006 | 7 |
Why?
| Nuclear Export Signals | 1 | 2006 | 7 |
Why?
| NIH 3T3 Cells | 1 | 2006 | 22 |
Why?
| Leucine | 1 | 2006 | 53 |
Why?
| Immunoglobulin Class Switching | 1 | 2006 | 17 |
Why?
| Hepatocytes | 1 | 2006 | 42 |
Why?
| Immunodominant Epitopes | 1 | 2006 | 14 |
Why?
| Xenopus Proteins | 1 | 2006 | 15 |
Why?
| Protein Kinases | 1 | 2006 | 64 |
Why?
| Dideoxynucleotides | 1 | 2005 | 4 |
Why?
| Asparagine | 1 | 2005 | 12 |
Why?
| Isoleucine | 1 | 2005 | 14 |
Why?
| CHO Cells | 1 | 2006 | 65 |
Why?
| HeLa Cells | 1 | 2006 | 107 |
Why?
| Glutamic Acid | 1 | 2006 | 66 |
Why?
| Acyclovir | 1 | 2005 | 28 |
Why?
| Valine | 1 | 2005 | 27 |
Why?
| Glutamine | 1 | 2005 | 27 |
Why?
| Xenopus laevis | 1 | 2006 | 49 |
Why?
| Zidovudine | 1 | 2005 | 23 |
Why?
| Cricetinae | 1 | 2006 | 130 |
Why?
| Enzyme Activation | 1 | 2006 | 177 |
Why?
| Phosphorylation | 1 | 2006 | 224 |
Why?
| Rats, Sprague-Dawley | 1 | 2006 | 257 |
Why?
| Cells, Cultured | 1 | 2006 | 447 |
Why?
| Time Factors | 1 | 2006 | 896 |
Why?
| Rats | 1 | 2006 | 530 |
Why?
| Racemases and Epimerases | 1 | 1996 | 3 |
Why?
| Isomerases | 1 | 1996 | 3 |
Why?
| Chemical Phenomena | 1 | 1996 | 43 |
Why?
| Chemistry | 1 | 1996 | 43 |
Why?
| Evolution, Molecular | 1 | 1996 | 45 |
Why?
| Phosphoenolpyruvate | 1 | 1996 | 4 |
Why?
| Protons | 1 | 1996 | 30 |
Why?
| Chromatography, Ion Exchange | 1 | 1995 | 36 |
Why?
| Chromatography, Gel | 1 | 1995 | 61 |
Why?
| Copper | 1 | 1995 | 36 |
Why?
| Cadmium | 1 | 1995 | 30 |
Why?
| Manganese | 1 | 1995 | 33 |
Why?
| Amino Acids | 1 | 1995 | 108 |
Why?
| Enzyme Inhibitors | 1 | 1996 | 216 |
Why?
| Plasmids | 1 | 1995 | 122 |
Why?
| Oxygen | 1 | 1996 | 179 |
Why?
| Male | 1 | 2006 | 1553 |
Why?
|
|
Wedekind's Networks
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|
